Figure 2.
Distribution of individual organ severity scores of cGVHD within global severity mild-moderate-severe staging categories. Data were obtained from the prospective study of the US cGVHD consortium (N = 298). The severity score accounts for both the magnitude of clinical manifestations and the degree of functional impairment. Reprinted with permission from Arai et al.19